PPIB and hepatitis A virus infection: This finding aligned with prior studies, which have reported rates of less than 50% for patients receiving DMARD treatment within 6 to 12 months of symptom onset.5,7 Our study indicates that receiving DMARDs with or without hepatitis B screening is associated with greater odds of meeting later quality care markers, such as radiographs, annual laboratory testing, annual physical examination, and PT, OT, or hand surgery referral.